JH

Jonathan Hirsch

CSO and founding team at Paradigm

San Francisco, California

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

Lifesciences
Biotechnology
Genomics
Molecular Biology
Bioinformatics
Entrepreneurship
Enterprise Software
Genetics
Semantic Technologies
Omics
Drug Discovery
Cell Biology
Cell Culture
Immunology
Cancer
Biochemistry
Ontologies
Commercialization
Pharmaceutical Industry
Drug Development

Education

Work Experience

  • Chief Strategy and Growth Officer

    2022

    Today, clinical trials are not offered to patients equitably. We think there’s an opportunity to create equitable access for any patient anywhere by reducing the burden on physicians to participate in clinical research, and speed up clinical trials in the process. I’m happy to share that we’re launching Paradigm and building the platform that will open up clinical trials as a care option for any patient! Read more in our press release here → https://www.paradigm.inc/news/paradigm-launches-to-rebuild-clinical-research

  • Co-Founder, Investor, and Chair of the Advisory Board

    2022

  • Investor

    2024

2021

  • Investor

    2021

  • Investor and Advisory Board

    2021

2022

  • Investor

    2022

2021

  • Advisor

    2021

2020

  • Strategic Advisor and Investor

    2020

  • Advisor, Real World Evidence & Data Platform

    2020

  • Senior Advisor

    2021

    Building a few new companies